Regulatory Alerts2024-10-18
Added
Consultation Paper on Capital Treatment for Structured Products and Infrastructure Investments for Insurers
The Monetary Authority of Singapore issued a consultation paper proposing differentiated capital treatment for infrastructure investments and revised rules for structured products under the RBC 2 framework. The document outlines specific regulatory changes aimed at aligning capital requirements with the risk profiles of these asset classes for licensed insurers. Stakeholders are invited to submit comments on the proposed measures by 22 November 2024.
Circular No: ID 14/24 18 October 2024 To Chief Executives All Licensed Insurers except for Captive Insurers, Marine Mutual Insurers and SPRVs Dear Sir/Madam CONSULTATION PAPER ON PROPOSED CAPITAL TREATMENT FOR STRUCTURED PRODUCTS AND INFRASTRUCTURE INVESTMENTS FOR INSURERS The Monetary Authority of Singapore (MAS) has issued the consultation paper on Proposed Capital Treatment for Structured Products and Infrastructure Investments for Insurers today. 2 With regard to the enhanced risk based capital (“RBC 2”) framework for insurers, MAS is proposing to introduce a differentiated capital treatment for infrastructure investments, and to revise the capital treatment of structured products, including those which are infrastructure in nature. 3 Please refer to Annex 1 for a copy of the consultation paper, which is also publicly available on the MAS website: https://www.mas.gov.sg/publications/consultations/2024/consultation-paper-on-capitaltreatment-for-structured-products-and-infrastructure-investments. 4 Please submit your comments on the consultation paper by 22 Nov 2024 via the link provided [Response to CP-P011-2024]. Thank you. Yours faithfully [sent via MASNET] DANIEL WANG EXECUTIVE DIRECTOR INSURANCE DEPARTMENT
2 ANNEX 1 – CONSULTATION ON CAPITAL TREATMENT FOR STRUCTURED PRODUCTS AND INFRASTRUCTURE INVESTMENTS FOR INSURERS Consultation on Capital Treatment for Structured Products and Infrastructure Investments.pdf